Search for: "BM" Results 1 - 20 of 430
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Apr 2024, 2:41 pm by vforberger
On March 26th of this year, the Wisconsin Supreme Court decided that further review in Amazon Logistics v. [read post]
2 Apr 2024, 4:50 am by Annsley Merelle Ward
BMS appealed on a number of grounds which essentially related to the following three questions: a) What is the correct approach to plausibility? [read post]
14 Feb 2024, 10:00 pm
ABSENT NOTE ACCELERATION, TIME BAR DIDN’T APPLYIn 2018, when a foreclosure action was brought against him, BM alleged that the case was barred by the governing statute of limitations, because the lender had failed to bring the case within a 6-year period. [read post]
8 Feb 2024, 12:59 pm by Daily Record Staff
Baltimore Medical System (BMS), the largest Federally Qualified Health Center (FQHC) system in Maryland, Thursday was recently awarded two grants that will support new and ongoing efforts to address disparities in cancer early detection among patients in Baltimore. [read post]
(“Sawai”) to suspend the manufacture and sale of Sawai’s pharmaceutical product (“Sawai’s Product”) developed and sold as a generic drug of Bristol-Myers Squibb (“BMS”)’s cancer drug “Sprycel®” (Case No. 2023 (Yo) 30214; AIK represented BMS in this case). [read post]
22 Dec 2023, 5:29 am by Rose Hughes
To encompass and embody: Applying the abstract principles of G2/21Applying G 2/21: Preliminary opinion from the referring Board of Appeal on post-filed evidence appeal (T 0116/18)UK divergence from the EPO on plausibility (Sandoz v BMS), Part 1: Is the "plausibility" test the same for both sufficiency and inventive step? [read post]
27 Nov 2023, 11:15 am by Rose Hughes
Recently, the judge in Sandoz v BMS ([2023] EWCA Civ 472) interpreted G2/21 as being close to an ab initio plausibility standard in line with the UK Supreme Court decision in Warner-Lambert. [read post]
23 Nov 2023, 4:00 am by Canadian Forum on Civil Justice
See: https://www.scc-csc.ca/judges-juges/spe-dis/bm-2013-05-27-eng.aspx#:~:text=In%20sum%2C%20without%20administrative%20tribunals,there%20is%20no%20going%20back. [2] For example, see Michelle A. [read post]
21 Nov 2023, 4:44 am by Roger Bate
Today, companies like Merck, Pfizer, Novartis, BMS, GSK, and others have reputations for quality. [read post]
6 Nov 2023, 5:51 am by Rose Hughes
In the recent UK decision Astellas v Teva [2023] EWHC 2571 (Pat) Mr Justice Mellor in the High Court considered sufficiency, inventive step and infringement of Astellas' formulation patent for mirabegron. [read post]
31 Oct 2023, 2:26 am by Rose Hughes
 (March 2023)UK divergence from the EPO on plausibility (Sandoz v BMS), Part 1: Is the "plausibility" test the same for both sufficiency and inventive step? [read post]
17 Oct 2023, 3:40 pm by Rik Lambers (Brinkhof)
– – – – – – – – – – – [1] At least, as to foreign judgments, this was considered in PI proceedings in DC Amsterdam 6 January 2023, DIVX/Netlfix, and confirmed in this decision. [2] In particular in view of CoA The Hague 15 August 2023, BMS/Sandoz (Apixaban). [3] Warner-Lambert Company LLC (Respondent) v Generics (UK) Ltd v, Mylan and another (Appellants) [2018] UKSC 56. [read post]
2 Oct 2023, 1:11 am by Rose Hughes
(March 2023)UK divergence from the EPO on plausibility (Sandoz v BMS), Part 1: Is the "plausibility" test the same for both sufficiency and inventive step? [read post]
29 Sep 2023, 2:52 am by Rose Hughes
The functional aspects of the invention therefore also allowed the patentee to also cross the inventive step hurdle.Further readingEPO Sufficiency versus UK PlausibilityUK divergence from the EPO on plausibility (Sandoz v BMS), Part 1: Is the "plausibility" test the same for both sufficiency and inventive step? [read post]
18 Sep 2023, 9:01 pm by Rodger Citron and Laura Dooley
 Justice Barrett, by contrast, argues—consistent with a number of recent Supreme Court cases, including the BMS case noted earlier—that state boundaries matter when evaluating personal jurisdiction. [read post]
3 Sep 2023, 7:33 pm by Sabrina I. Pacifici
The Verge: “The company denies its new government deal enables ‘general purpose’ biometric surveillance. [read post]
28 Jul 2023, 5:58 am by Jocelyn Bosse
 Here’s a brief summary of what you missed from the IPKat.IP GenerallyKatfriend Alessandro Cerri provided an update on the intellectual property-related aspects of the European Commission's recent communication of its strategy on Web 4.0 and virtual worlds.PatentsRose Hughes gave us a two-part analysis of the Court of Appeal of England & Wales decision in Sandoz v BMS and how it diverged from the EPO's approach to plausibility. [read post]